Copyright Reports & Markets. All rights reserved.

Global Klebsiella Pneumoniae Infection Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Klebsiella Pneumoniae Infection Drug Market Overview

      • 1.1 Product Overview and Scope of Klebsiella Pneumoniae Infection Drug
      • 1.2 Klebsiella Pneumoniae Infection Drug Segment by Type
        • 1.2.1 Global Klebsiella Pneumoniae Infection Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 ATI-1503
        • 1.2.3 CA-824
        • 1.2.4 CC-1807
        • 1.2.5 Cefiderocol
        • 1.2.6 Debio-1454
        • 1.2.7 EBX-004
        • 1.2.8 Others
      • 1.3 Klebsiella Pneumoniae Infection Drug Segment by Application
        • 1.3.1 Klebsiella Pneumoniae Infection Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.3 Global Klebsiella Pneumoniae Infection Drug Market by Region
        • 1.3.1 Global Klebsiella Pneumoniae Infection Drug Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Klebsiella Pneumoniae Infection Drug Market Size
        • 1.4.1 Global Klebsiella Pneumoniae Infection Drug Revenue (2014-2025)
        • 1.4.2 Global Klebsiella Pneumoniae Infection Drug Production (2014-2025)

      2 Global Klebsiella Pneumoniae Infection Drug Market Competition by Manufacturers

      • 2.1 Global Klebsiella Pneumoniae Infection Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Klebsiella Pneumoniae Infection Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Klebsiella Pneumoniae Infection Drug Production Sites, Area Served, Product Types
      • 2.5 Klebsiella Pneumoniae Infection Drug Market Competitive Situation and Trends
        • 2.5.1 Klebsiella Pneumoniae Infection Drug Market Concentration Rate
        • 2.5.2 Klebsiella Pneumoniae Infection Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Klebsiella Pneumoniae Infection Drug Production Market Share by Regions

      • 3.1 Global Klebsiella Pneumoniae Infection Drug Production Market Share by Regions
      • 3.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Klebsiella Pneumoniae Infection Drug Production
        • 3.4.1 North America Klebsiella Pneumoniae Infection Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Klebsiella Pneumoniae Infection Drug Production
        • 3.5.1 Europe Klebsiella Pneumoniae Infection Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Klebsiella Pneumoniae Infection Drug Production (2014-2019)
        • 3.6.1 China Klebsiella Pneumoniae Infection Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Klebsiella Pneumoniae Infection Drug Production (2014-2019)
        • 3.7.1 Japan Klebsiella Pneumoniae Infection Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Klebsiella Pneumoniae Infection Drug Consumption by Regions

      • 4.1 Global Klebsiella Pneumoniae Infection Drug Consumption by Regions
      • 4.2 North America Klebsiella Pneumoniae Infection Drug Consumption (2014-2019)
      • 4.3 Europe Klebsiella Pneumoniae Infection Drug Consumption (2014-2019)
      • 4.4 China Klebsiella Pneumoniae Infection Drug Consumption (2014-2019)
      • 4.5 Japan Klebsiella Pneumoniae Infection Drug Consumption (2014-2019)

      5 Global Klebsiella Pneumoniae Infection Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Klebsiella Pneumoniae Infection Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Klebsiella Pneumoniae Infection Drug Price by Type (2014-2019)
      • 5.4 Global Klebsiella Pneumoniae Infection Drug Production Growth by Type (2014-2019)

      6 Global Klebsiella Pneumoniae Infection Drug Market Analysis by Applications

      • 6.1 Global Klebsiella Pneumoniae Infection Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Klebsiella Pneumoniae Infection Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Klebsiella Pneumoniae Infection Drug Business

      • 7.1 Acies Bio doo
        • 7.1.1 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.1.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Appili Therapeutics
        • 7.2.1 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.2.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Debiopharm International SA
        • 7.3.1 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.3.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Evaxion Biotech ApS
        • 7.4.1 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.4.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 F. Hoffmann-La Roche Ltd
        • 7.5.1 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.5.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 FOB Synthesis Inc
        • 7.6.1 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.6.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 ImmunoClin Corp
        • 7.7.1 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.7.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Innovation Pharmaceuticals Inc
        • 7.8.1 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.8.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Kyorin Pharmaceutical Co Ltd
        • 7.9.1 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.9.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Melinta Therapeutics Inc
        • 7.10.1 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 7.10.2 Klebsiella Pneumoniae Infection Drug Product Introduction, Application and Specification
        • 7.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Nosopharm SAS
      • 7.12 Peptilogics Inc
      • 7.13 Pfizer Inc
      • 7.14 Phico Therapeutics Ltd
      • 7.15 Sarepta Therapeutics Inc
      • 7.16 Shionogi & Co Ltd
      • 7.17 Syntiron LLC
      • 7.18 Tetraphase Pharmaceuticals Inc

      8 Klebsiella Pneumoniae Infection Drug Manufacturing Cost Analysis

      • 8.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
      • 8.4 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Klebsiella Pneumoniae Infection Drug Distributors List
      • 9.3 Klebsiella Pneumoniae Infection Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Klebsiella Pneumoniae Infection Drug Market Forecast

      • 11.1 Global Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast
        • 11.1.1 Global Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Klebsiella Pneumoniae Infection Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Klebsiella Pneumoniae Infection Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Klebsiella Pneumoniae Infection Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Klebsiella Pneumoniae Infection Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Klebsiella Pneumoniae Infection Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Klebsiella Pneumoniae Infection Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Klebsiella Pneumoniae Infection Drug Consumption Forecast (2019-2025)
      • 11.4 Global Klebsiella Pneumoniae Infection Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Klebsiella Pneumoniae Infection Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Klebsiella Pneumoniae Infection Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Klebsiella Pneumoniae Infection Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Klebsiella Pneumoniae Infection Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Acies Bio doo
        Appili Therapeutics
        Debiopharm International SA
        Evaxion Biotech ApS
        F. Hoffmann-La Roche Ltd
        FOB Synthesis Inc
        ImmunoClin Corp
        Innovation Pharmaceuticals Inc
        Kyorin Pharmaceutical Co Ltd
        Melinta Therapeutics Inc
        Nosopharm SAS
        Peptilogics Inc
        Pfizer Inc
        Phico Therapeutics Ltd
        Sarepta Therapeutics Inc
        Shionogi & Co Ltd
        Syntiron LLC
        Tetraphase Pharmaceuticals Inc

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        ATI-1503
        CA-824
        CC-1807
        Cefiderocol
        Debio-1454
        EBX-004
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now